Weiwei Gong
Ismaninger Str. 22
Munich, BY 81576, Germany
Munich, BY 81576, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.
Journal: Pathophysiology : the official journal of the International Society for Pathophysiology
Published: February 06, 2026
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Mucopolysaccharidosis IVA: A 10-Year Follow-Up from a Single-Center Experience in China.
Journal: Transplantation and cellular therapy
Published: November 15, 2025
Sleep quality and incidence of diabetes in 0.5 million Chinese adults.
Journal: BMC public health
Published: October 08, 2025
Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer.
Journal: Frontiers in molecular biosciences
Published: May 01, 2024
Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer.
Journal: American journal of cancer research
Published: January 23, 2023
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression.
Journal: Life (Basel, Switzerland)
Published: August 26, 2022
Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer.
Journal: American journal of translational research
Published: October 16, 2020
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Journal: Journal of ovarian research
Published: July 21, 2020
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 06, 2019
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
Journal: PloS one
Published: November 07, 2018
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Journal: BMC cancer
Published: June 29, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026